pharmacogenetics

The TAILOR-PCI trial did not meet its primary endpoint but did find that genetic testing led to a reduction in adverse events, though not as much as expected.

Using Revel Health's health action platform, the partners will communicate and promote CLS's genetic testing offering to Medicare Advantage members.

The firm can now tell customers if their genotypes may impact their response to clopidogrel and citalopram without the need for confirmatory testing.

The MAC will consider PGx testing reasonable and necessary after a physician has narrowed a patient's treatment options to specific medications.

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

Under the LCD, pharmacogenomic tests are covered when medications are being considered for use that are known to have a clinically actionable gene-drug interaction.

The group said the recommendations aim to standardize and improve warfarin response genotyping assays.

The new distribution partnership is for the US acute care market where, until now, Spartan was selling directly.